World's Best Scientists 2026 revealed!
Ramesh A. Shivdasani

Ramesh A. Shivdasani

D-Index & Metrics

Molecular Biology

D-Index
97
Citations
33349
World Ranking
594
National Ranking
326

Medicine

D-Index
97
Citations
33712
World Ranking
9308
National Ranking
4803

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Ramesh A. Shivdasani is affiliated with Harvard University in the United States. Their research spans multiple fields with a primary focus on Biochemistry, Genetics and Molecular Biology, and Medicine. Within these areas, key subfields of study include Molecular Biology, Oncology, Genetics, Surgery, and Cancer Research.

The scientist's work addresses several major topics:

  • Cancer Cells and Metastasis
  • Digestive system and related health
  • Epigenetics and DNA Methylation
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic function and diabetes
  • Cancer Genomics and Diagnostics
  • Tissue Engineering and Regenerative Medicine

Shivdasani has contributed extensively in various publication venues, with frequent appearances in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell stem cell
  • Gastroenterology
  • Developmental Cell
  • Nature

Some recent papers authored or co-authored by Shivdasani include:

  • Distinct Mesenchymal Cell Populations Generate the Essential Intestinal BMP Signaling Gradient (2020, Cell stem cell)
  • Ascl2-Dependent Cell Dedifferentiation Drives Regeneration of Ablated Intestinal Stem Cells (2020, Cell stem cell)
  • Cellular and molecular architecture of the intestinal stem cell niche (2020, Nature Cell Biology)
  • Replicational Dilution of H3K27me3 in Mammalian Cells and the Role of Poised Promoters (2020, Molecular Cell)
  • Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development (2020, Developmental Cell)

The scientist frequently collaborates with other researchers, including Shariq Madha, Pratik Singh, Guodong Tie, Neil McCarthy, and Unmesh Jadhav.

Ramesh A. Shivdasani was awarded membership in the Association of American Physicians, highlighting recognition within their professional community.

Best Publications

  • Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

    Aleksandar D. Kostic;Dirk Gevers;Chandra Sekhar Pedamallu;Chandra Sekhar Pedamallu;Monia Michaud

  • Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.

    Ramesh A. Shivdasani;Erica L. Mayer;Erica L. Mayer;Stuart H. Orkin;Stuart H. Orkin

  • SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

    Adam J. Bass;Adam J. Bass;Hideo Watanabe;Hideo Watanabe;Craig H. Mermel;Craig H. Mermel;Soyoung Yu

  • Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.

    Ramesh A Shivdasani;Margery F Rosenblatt;Dorothea Zucker-Franklin;Carl W Jackson

  • Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

    Maina Lepourcelet;Ying-Nan P. Chen;Huisheng Wang

  • The transcriptional control of hematopoiesis.

    Ramesh A. Shivdasani;Stuart H. Orkin

  • A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development

    Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Yuko Fujiwara;Michael A. McDevitt;Stuart H. Orkin

  • Dynamic Visualization of Thrombopoiesis Within Bone Marrow

    Tobias Junt;Harald Schulze;Zhao Chen;Steffen Massberg

  • CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

    Ron Firestein;Adam Bass;So Young Kim;Ian Frederick Dunn

  • The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

    Mark M. Pomerantz;Nasim Ahmadiyeh;Nasim Ahmadiyeh;Li Jia;Paula Herman

  • Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

    Kimio Yonesaka;Kreshnik Zejnullahu;Isamu Okamoto;Taroh Satoh

  • Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.

    Joseph E. Italiano;Patrick Lecine;Ramesh A. Shivdasani;John H. Hartwig;John H. Hartwig

  • MicroRNAs : regulators of gene expression and cell differentiation

    Ramesh A. Shivdasani

  • Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

    Anna Bielinska;Ramesh A. Shivdasani;Liquan Zhang;Gary J. Nabel

  • Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples

    Laura E. MacConaill;Catarina D. Campbell;Sarah M. Kehoe;Adam J. Bass

  • The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

    Mark M Pomerantz;Fugen Li;David Y Takeda;David Y Takeda;Romina Lenci

  • Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets

    Paresh Vyas;Kenneth Ault;Carl W. Jackson;Stuart H. Orkin

  • Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.

    J Souglakos;J Philips;R Wang;S Marwah

  • Anion Exchanger 1 (Band 3) Is Required to Prevent Erythrocyte Membrane Surface Loss but Not to Form the Membrane Skeleton

    Luanne L Peters;Ramesh A Shivdasani;Shih-Chun Liu;Manjit Hanspal

  • Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

    Joshua M Francis;Joshua M Francis;Adam Kiezun;Alex H Ramos;Alex H Ramos;Stefano Serra

Frequent Co-Authors

Stuart H. Orkin
Stuart H. Orkin Harvard University
Joseph E. Italiano
Joseph E. Italiano Boston Children's Hospital
Shuji Ogino
Shuji Ogino Brigham and Women's Hospital
John H. Hartwig
John H. Hartwig Brigham and Women's Hospital
Matthew Meyerson
Matthew Meyerson Harvard University
William C. Hahn
William C. Hahn Dana-Farber Cancer Institute
Matthew H. Kulke
Matthew H. Kulke Boston Medical Center
Myles Brown
Myles Brown Harvard University
X. Shirley Liu
X. Shirley Liu Harvard University
Yuko Fujiwara
Yuko Fujiwara Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Molecular Biology can open the door to dynamic careers in science and healthcare. If you’re considering flexible study options, many students transition from biology backgrounds to health professions through programs like msn direct entry programs online. These programs are designed for non-nurses seeking accelerated pathways to advanced practice nursing roles.

Accreditation is crucial when choosing an online university. Schools such as Capella are frequently compared for their credentials—read more about capella university nursing accreditation to ensure you select a reputable institution.

For registered nurses wanting to advance, rn to msn bridge programs offer affordable, flexible options to move into leadership or specialized roles. Many of these pathways are available at non profit online colleges, which often provide quality education with a mission-driven focus.

Whether your interest lies in research, teaching, or clinical practice, online degrees create new possibilities for career growth in molecular biology and related fields.

Best Scientists Citing Ramesh A. Shivdasani

Trending Scientists

Recently Published Articles